BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21246116)

  • 1. Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.
    Sharma P; Shathasivam T; Ignatchenko V; Kislinger T; Gramolini AO
    Mol Biosyst; 2011 Apr; 7(4):1185-96. PubMed ID: 21246116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.
    Shathasivam T; Kislinger T; Gramolini AO
    J Cell Mol Med; 2010 Dec; 14(12):2702-20. PubMed ID: 20874719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an FHL1 protein complex containing gamma-actin and non-muscle myosin IIB by analysis of protein-protein interactions.
    Wang L; Miao J; Li L; Wu D; Zhang Y; Peng Z; Zhang L; Yuan Z; Sun K
    PLoS One; 2013; 8(11):e79551. PubMed ID: 24265776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
    Lukash T; Agback T; Dominguez F; Shiliaev N; Meshram C; Frolova EI; Agback P; Frolov I
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
    Yang Z; Browning CF; Hallaq H; Yermalitskaya L; Esker J; Hall MR; Link AJ; Ham AJ; McGrath MJ; Mitchell CA; Murray KT
    Cardiovasc Res; 2008 Jun; 78(3):449-57. PubMed ID: 18281375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
    Wei X; Zhang H
    Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly.
    McGrath MJ; Cottle DL; Nguyen MA; Dyson JM; Coghill ID; Robinson PA; Holdsworth M; Cowling BS; Hardeman EC; Mitchell CA; Brown S
    J Biol Chem; 2006 Mar; 281(11):7666-83. PubMed ID: 16407297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
    Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
    Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1).
    Ng EK; Lee SM; Li HY; Ngai SM; Tsui SK; Waye MM; Lee CY; Fung KP
    J Cell Biochem; 2001 Apr 2-27; 82(1):1-10. PubMed ID: 11400158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
    Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
    IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic effect of FHL1 on neuromuscular junction and myotube formation via insulin-like growth factor and myostatin signaling pathways.
    Wu J; Zhao K; Du Z; Chen Y; Zhang F; Jiang W; Zheng J; Wu X; Shen C; Xiao X
    Biochem Biophys Res Commun; 2021 Jan; 537():125-131. PubMed ID: 33401146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
    Cowling BS; McGrath MJ; Nguyen MA; Cottle DL; Kee AJ; Brown S; Schessl J; Zou Y; Joya J; Bönnemann CG; Hardeman EC; Mitchell CA
    J Cell Biol; 2008 Dec; 183(6):1033-48. PubMed ID: 19075112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
    Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
    J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL1 is a major host factor for chikungunya virus infection.
    Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Bertrand-Legout A; Gueneau L; Juntas-Morales R; Ben Yaou R; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
    Nature; 2019 Oct; 574(7777):259-263. PubMed ID: 31554973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
    Matsumoto M; Kawakami K; Enokida H; Toki K; Matsuda R; Chiyomaru T; Nishiyama K; Kawahara K; Seki N; Nakagawa M
    Int J Mol Med; 2010 Aug; 26(2):241-7. PubMed ID: 20596604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
    Lin J; Ding L; Jin R; Zhang H; Cheng L; Qin X; Chai J; Ye Q
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1613-8. PubMed ID: 19401155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
    Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
    PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
    Wilding BR; McGrath MJ; Bonne G; Mitchell CA
    J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
    Ding L; Niu C; Zheng Y; Xiong Z; Liu Y; Lin J; Sun H; Huang K; Yang W; Li X; Ye Q
    J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.